首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1917789

空間基因組學和轉錄組學市場——2026-2031年預測

Spatial Genomics and Transcriptomics Market - Forecast from 2026 to 2031

出版日期: 2026年01月06日 | 出版商:

Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計空間基因組學和轉錄組學市場將從 2025 年的 732,413,000 美元成長到 2031 年的 1,435,830,000 美元，複合年成長率為 11.87%。

空間基因組學和轉錄組學市場正迅速擴張，這主要得益於對精準醫療和標靶治療技術需求的激增。學術機構正將這些工具整合到疾病研究計畫中，以更深入地了解細胞異質性。研究人員正利用高解析度空間圖譜進一步了解腫瘤微環境和組織結構。生物技術公司正在部署支援單細胞和組織尺度分析的先進定序平台。

空間基因組學和轉錄組學技術能夠視覺化和分析完整組織環境中的基因表現模式，從而保留傳統批量定序中遺失的空間組織資訊。這些方法將基因組或轉錄組分析與形態學數據相結合，揭示細胞相互作用、異質性以及微環境的影響，這對於理解疾病進展和治療反應至關重要。在腫瘤學、神經病學、免疫學和發育生物學等領域的應用正在推動市場強勁成長，空間資訊有助於提高生物標記的發現、診斷準確性和藥物標靶識別。

關鍵的成長要素在於其在藥物發現和開發領域的應用不斷擴展，尤其是在癌症和神經系統疾病領域。空間分析有助於理解複雜的病理過程，並為靶向干預提供指南。在人類細胞圖譜等計畫的支持下，基因組學和轉錄組學研究的日益增多，正推動著遺傳疾病研究領域對空間分析的更大應用。學術機構的廣泛應用使得對多種病理進行全面的形態學和分子分析成為可能。單細胞解析度轉錄組學的日益普及，以及雷射捕獲晶粒等技術的應用，解決了組織異質性問題，並實現了空間數據的保存。

從地區來看，由於對病理學研究的策略性投資、對轉錄組學研發的重視以及支持高通量定序和空間解析度進步的強大基礎設施，預計北美將佔據主要佔有率。

代表性產品包括 10x Genomics 的 Visium Spatial Gene Expression，它能繪製新鮮冷凍或 FFPE 組織中具有形態學背景的全轉錄組圖譜，為發育、病理和轉化研究提供見解；以及 NanoString Technologies 的 GeoMx Digital Spatial Profiler，它能從單個載玻片上進行空間轉錄組學和蛋白質體學分析，它能從單一載玻片上柔軟性。

主要企業包括 Natera Inc.、10x Genomics、Dovetail Genomics、Illumina, Inc. 和 S2 Genomics, Inc.。這些公司正在推廣整合次世代定序、成像和生物資訊學的平台，以實現高度多重、高解析度的空間分析。

總體而言，市場正在穩步發展，透過保存組織背景，有可能徹底改變人們對疾病的理解，隨著慢性疾病變得越來越複雜，調查變得越來越精細，市場有望加速精準診斷和治療。

本報告的主要優勢：

深入分析：獲得主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
市場促進因素和未來趨勢：探索市場促進因素和關鍵趨勢，並了解它們將如何影響未來的市場發展。
可操作的建議：利用這些見解，在快速變化的環境中做出策略決策，並發現新的商機和收入來源。
受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

以下是一些公司如何使用這份報告的範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍：

2021年至2025年的歷史數據和2026年至2031年的預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區分類的收入和預測評估，包括國家/地區
公司概況（策略、產品、財務資訊、關鍵發展等）

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 德國
- 法國
- 英國
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 印尼
- 泰國
- 其他

第9章競爭格局與分析

主要企業和策略分析
市佔率分析
合併、收購、協議和合作
競爭對手儀錶板

第10章：公司簡介

10x Genomics
Illumina, Inc.
S2 Genomics, Inc.
Bruker Spatial Biology, Inc.
Velsera
Bio-Techne
Akoya Biosciences
Standard BioTools
Vizgen Inc.
Agilent Technologies, Inc.

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要收益
調查方法
簡稱

簡介目錄

Product Code: KSI061615762

Spatial Genomics And Transcriptomics Market is forecasted to rise at a 11.87% CAGR, reaching USD 1435.83 million in 2031 from USD 732.413 million in 2025.

The spatial genomics and transcriptomics market is expanding rapidly, driven by surging demand for technologies enabling precision medicine and targeted therapy development. Academic institutions are integrating these tools into disease research programs for deeper insights into cellular heterogeneity. Researchers are leveraging high-resolution spatial mapping to dissect tumor microenvironments and tissue architecture. Biotech firms are introducing advanced sequencing platforms supporting single-cell and tissue-scale analysis.

Spatial genomics and transcriptomics technologies facilitate the visualization and analysis of gene expression patterns within intact tissue contexts, preserving spatial organization lost in traditional bulk sequencing. These approaches combine genomic or transcriptomic profiling with morphological data, revealing cellular interactions, heterogeneity, and microenvironmental influences critical for understanding disease progression and therapeutic response. The market is growing robustly, fueled by applications in oncology, neurology, immunology, and developmental biology, where spatial context enhances biomarker discovery, diagnostic accuracy, and drug target identification.

Key growth drivers include escalating applications in drug discovery and development, particularly for cancer and neurological disorders, where spatial profiling elucidates complex pathologies and informs targeted interventions. Increasing research in genomics and transcriptomics, supported by initiatives like the Human Cell Atlas, amplifies adoption in academic settings for studying genetically derived diseases. Widespread use in academic facilities provides comprehensive morphological and molecular analyses across diverse conditions. Rising adoption of transcriptomics for single-cell resolution, aided by techniques like laser capture microdissection, addresses tissue heterogeneity and enables archival spatial data preservation.

Geographically, North America is predicted to hold a significant share, attributed to strategic investments in pathology research, emphasis on transcriptomics R&D, and robust infrastructure supporting high-throughput sequencing and spatial resolution advancements.

Prominent products include 10x Genomics' Visium Spatial Gene Expression, which maps whole-transcriptome profiles with morphological context in fresh frozen or FFPE tissues for insights into development, pathology, and translational studies. NanoString Technologies' GeoMx Digital Spatial Profiler enables spatial transcriptomics and proteomics from single slides, offering flexibility from discovery to translational workflows.

Leading companies include Natera Inc., 10x Genomics, Dovetail Genomics, Illumina, Inc., and S2 Genomics, Inc. These entities advance platforms integrating next-generation sequencing, imaging, and bioinformatics for high-plex, high-resolution spatial profiling.

Overall, the market is advancing steadily, positioned to revolutionize disease understanding through preserved tissue context, accelerating precision diagnostics and therapeutics amid rising chronic disease complexity and research intensity.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Spatial Genomics and Transcriptomics Market Segmentation

By Type
Spatial Genomics
In-Situ Hybridization
Next-Generation Sequencing
Others
Spatial Transcriptomics
Sequencing-Based
Probe-Based
Imaging-Based
By Application
Neurology
Oncology
Immunology
Developmental Biology
Others
By End-User
Pharmaceutical & Biotech Companies
Academic & Research Institutes
Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY TYPE

5.1. Introduction
5.2. Spatial Genomics
- 5.2.1. In-Situ Hybridization
- 5.2.2. Next-Generation Sequencing
- 5.2.3. Others
5.3. Spatial Transcriptomics
- 5.3.1. Sequencing-Based
- 5.3.2. Probe-Based
- 5.3.3. Imaging-Based

6. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY APPLICATION

6.1. Introduction
6.2. Neurology
6.3. Oncology
6.4. Immunology
6.5. Developmental Biology
6.6. Others

7. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY END-USER

7.1. Introduction
7.2. Pharmaceutical & Biotech Companies
7.3. Academic & Research Institutes
7.4. Others

8. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others